Literature DB >> 20501646

The deubiquitinating enzyme USP26 is a regulator of androgen receptor signaling.

Annette M G Dirac1, René Bernards.   

Abstract

The androgen receptor (AR) is a member of the nuclear receptor superfamily and is essential for male sexual development and maturation, as well as prostate cancer development. Regulation of AR signaling activity depends on several posttranslational modifications, one of these being ubiquitination. We screened a short hairpin library targeting members of the deubiquitination enzyme family and identified the X-linked deubiquitination enzyme USP26 as a novel regulator of AR signaling. USP26 is a nuclear protein that binds to AR via three important nuclear receptor interaction motifs, and modulates AR ubiquitination, consequently influencing AR activity and stability. Our data suggest that USP26 assembles with AR and other cofactors in subnuclear foci, and serves to counteract hormone-induced AR ubiquitination, thereby contributing to the regulation of AR transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501646     DOI: 10.1158/1541-7786.MCR-09-0424

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  42 in total

Review 1.  The role of deubiquitinating enzymes in spermatogenesis.

Authors:  Bharathi Suresh; Junwon Lee; Seok-Ho Hong; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Cell Mol Life Sci       Date:  2015-09-08       Impact factor: 9.261

Review 2.  Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

Authors:  Shan Wang; Dede N Ekoue; Ganesh V Raj; Ralf Kittler
Journal:  Cancer Lett       Date:  2018-09-11       Impact factor: 8.679

3.  The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin.

Authors:  Shu-Ting Chen; Maiko Okada; Ryuichiro Nakato; Kosuke Izumi; Masashige Bando; Katsuhiko Shirahige
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

4.  Disruption of ubiquitin specific protease 26 gene causes male subfertility associated with spermatogenesis defects in mice†.

Authors:  Hong Tian; Yongwei Huo; Jie Zhang; Shangshu Ding; Zhiyong Wang; Hecheng Li; Lirong Wang; Ming Lu; Sen Liu; Shudong Qiu; Qiuyang Zhang
Journal:  Biol Reprod       Date:  2019-04-01       Impact factor: 4.285

Review 5.  Molecular pathogenesis and progression of prostate cancer.

Authors:  Randy Schrecengost; Karen E Knudsen
Journal:  Semin Oncol       Date:  2013-06       Impact factor: 4.929

6.  Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer.

Authors:  Karen E Knudsen; William Kevin Kelly
Journal:  Expert Rev Endocrinol Metab       Date:  2011-05

7.  A Novel Missense Mutation in USP26 Gene Is Associated With Nonobstructive Azoospermia.

Authors:  Qian Ma; Yuchi Li; Huan Guo; Cailing Li; Jianbo Chen; Manling Luo; Zhimao Jiang; Honggang Li; Yaoting Gui
Journal:  Reprod Sci       Date:  2016-04-18       Impact factor: 3.060

8.  Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy.

Authors:  Anna Pluciennik; Yuhong Liu; Elana Molotsky; Gregory B Marsh; Bedri Ranxhi; Frederick J Arnold; Sophie St-Cyr; Beverly Davidson; Naemeh Pourshafie; Andrew P Lieberman; Wei Gu; Sokol V Todi; Diane E Merry
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

9.  Relationship between serum response factor and androgen receptor in prostate cancer.

Authors:  Maria Prencipe; Amanda O'Neill; Gillian O'Hurley; Lan K Nguyen; Aurelie Fabre; Anders Bjartell; William M Gallagher; Colm Morrissey; Elaine W Kay; R William Watson
Journal:  Prostate       Date:  2015-08-07       Impact factor: 4.104

10.  USP22 regulates oncogenic signaling pathways to drive lethal cancer progression.

Authors:  Randy S Schrecengost; Jeffry L Dean; Jonathan F Goodwin; Matthew J Schiewer; Mark W Urban; Timothy J Stanek; Robyn T Sussman; Jessica L Hicks; Ruth C Birbe; Rossitza A Draganova-Tacheva; Tapio Visakorpi; Angelo M DeMarzo; Steven B McMahon; Karen E Knudsen
Journal:  Cancer Res       Date:  2013-11-06       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.